University Health Network, Toronto, Ontario, Canada.
Circ Res. 2011 Nov 11;109(11):1309-18. doi: 10.1161/CIRCRESAHA.110.232918. Epub 2011 Oct 6.
Ventricular fibrillation (VF) leads to global ischemia. The modulation of ischemia-dependent pathways may alter the electrophysiological evolution of VF.
We addressed the hypotheses that there is regional disease-related expression of K(ATP) channels in human cardiomyopathic hearts and that K(ATP) channel blockade promotes spontaneous VF termination by attenuating spatiotemporal dispersion of refractoriness.
In a human Langendorff model, electric mapping of 6 control and 9 treatment (10 μmol/L glibenclamide) isolated cardiomyopathic hearts was performed. Spontaneous defibrillation was studied and mean VF cycle length was compared regionally at VF onset and after 180 seconds between control and treatment groups. K(ATP) subunit gene expression was compared between LV endocardium versus epicardium in myopathic hearts. Spontaneous VF termination occurred in 1 of 6 control hearts and 7 of 8 glibenclamide-treated hearts (P=0.026). After 180 seconds of ischemia, a transmural dispersion in VF cycle length was observed between epicardium and endocardium (P=0.001), which was attenuated by glibenclamide. There was greater gene expression of all K(ATP) subunit on the endocardium compared with the epicardium (P<0.02). In an ischemic rat heart model, transmural dispersion of refractoriness (ΔERP(Transmural)=ERP(Epicardium)-ERP(Endocardium)) was verified with pacing protocols. ΔERP(Transmural) in control was 5 ± 2 ms and increased to 36 ± 5 ms with ischemia. This effect was greatly attenuated by glibenclamide (ΔERP(Transmural) for glibenclamide+ischemia=4.9 ± 4 ms, P=0.019 versus control ischemia).
K(ATP) channel subunit gene expression is heterogeneously altered in the cardiomyopathic human heart. Blockade of K(ATP) channels promotes spontaneous defibrillation in cardiomyopathic human hearts by attenuating the ischemia-dependent spatiotemporal heterogeneity of refractoriness during early VF.
心室颤动(VF)可导致全层心肌缺血。缺血依赖途径的调制可能会改变 VF 的电生理演变。
我们提出了以下假设:在人类扩张型心肌病心脏中存在与疾病相关的局部 K(ATP)通道表达,并且 K(ATP)通道阻断通过减轻复极离散的时空异质性来促进自发性 VF 终止。
在人类 Langendorff 模型中,对 6 个对照和 9 个治疗(10 μmol/L 格列本脲)离体心肌病心脏进行电描记。研究自发性除颤,并在对照和治疗组之间比较 VF 起始时和 180 秒时的局部平均 VF 周期长度。在心肌病心脏中比较 LV 心内膜与心外膜之间 K(ATP)亚基基因表达。在 6 个对照心脏中有 1 个,在 8 个格列本脲治疗心脏中有 7 个发生自发性 VF 终止(P=0.026)。缺血 180 秒后,在心外膜和心内膜之间观察到 VF 周期长度的跨壁离散(P=0.001),格列本脲可减轻这种离散。与心外膜相比,心内膜上所有 K(ATP)亚基的基因表达更高(P<0.02)。在缺血大鼠心脏模型中,通过起搏方案验证了复极离散度的跨壁差异(ΔERP(Transmural)=ERP(心外膜)-ERP(心内膜))。对照的 ΔERP(Transmural)为 5±2 ms,缺血时增加到 36±5 ms。格列本脲可大大减轻这种作用(格列本脲+缺血时的 ΔERP(Transmural)=4.9±4 ms,P=0.019 与对照缺血相比)。
在扩张型心肌病心脏中,K(ATP)通道亚基基因表达存在异质性改变。在扩张型心肌病心脏中,K(ATP)通道阻断通过减轻早期 VF 时复极离散度的缺血依赖性时空异质性,促进自发性除颤。